Dr. Somerset is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
777 Bannock St
Denver, CO 80204Phone+1 303-602-6076
Education & Training
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2013 - 2014
University of ColoradoResidency, Pathology-Anatomic and Clinical, 2009 - 2013- University of Colorado School of Medicine Anschutz Medical CampusClass of 2009
Certifications & Licensure
CO State Medical License 2012 - 2025
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 6 citationsThe programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell ca...Cera Nieto, Bettina Miller, Nathaniel Alzofon, Tugy Chimed, Jack Himes
Journal of the National Cancer Institute. 2023-11-08 - 4 citationsStudying immunotherapy resistance in a melanoma autologous humanized mouse xenograftJohn Morton, Nathaniel Alzofon, Stephen B. Keysar, Tugs-Saikhan Chimed, Julie Reisinger
Molecular Cancer Research. 2021-02-01 - 94 citationsCancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.Karina E. Gomez, Fanglong Wu, Stephen B. Keysar, John Morton, Bettina Miller
Cancer Research. 2020-08-14
Journal Articles
- Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients with Oral Cavity CancerDing Ding, Whitney Sumner, David Raben, Mohammad Hararah, Jessica McDermott, Sana D Karam, Julie Goddard, Hilary Somerset, JAMA
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerHilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
- Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck CancersSana D Karam, Dallin Milner, Hilary Somerset, Antonio Jimeno, David Raben, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
